Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Clarke

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Neurotoxicology|May 17, 2016
A global portrait of the manganese industry-A socioeconomic perspectiveCarl Clarke, Sophie Upson
Clinical Evidence|February 27, 2003
Parkinson's diseaseCarl Clarke, A Moore
Clinical Evidence|September 17, 2002
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|September 2, 2005
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|November 24, 2004
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|January 18, 2005
Parkinson's diseaseCarl Clarke, A Peter Moore
Computers in Human Behavior Reports|September 27, 2021
Development and validation of the e-Work Self-Efficacy Scale to assess digital competencies in remote workingCarlo Tramontano, Christine Grant, Carl Clarke
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
Pilot and Feasibility Studies|August 10, 2021
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trialSarah Scobie, Sue Jowett, Tosin Lambe, et al.
Plos One|January 28, 2015
The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descentSharon C Yates, Amen Zafar, Erzsebet M Rabai, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neurotoxicology|May 17, 2016
A global portrait of the manganese industry-A socioeconomic perspectiveCarl Clarke, Sophie Upson
Clinical Evidence|February 27, 2003
Parkinson's diseaseCarl Clarke, A Moore
Clinical Evidence|September 17, 2002
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|September 2, 2005
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|November 24, 2004
Parkinson's diseaseCarl Clarke, A Peter Moore
Clinical Evidence|January 18, 2005
Parkinson's diseaseCarl Clarke, A Peter Moore
Computers in Human Behavior Reports|September 27, 2021
Development and validation of the e-Work Self-Efficacy Scale to assess digital competencies in remote workingCarlo Tramontano, Christine Grant, Carl Clarke
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
Pilot and Feasibility Studies|August 10, 2021
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trialSarah Scobie, Sue Jowett, Tosin Lambe, et al.
Plos One|January 28, 2015
The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descentSharon C Yates, Amen Zafar, Erzsebet M Rabai, et al.
Pageof 2